---
figid: PMC6923788__mdz281f1
figtitle: Signaling by the phosphatidylinositol-3-kinase (PI3K)-AKT- mammalian target
  of rapamycin (mTOR) pathway
organisms:
- NA
pmcid: PMC6923788
filename: mdz281f1.jpg
figlink: /pmc/articles/PMC6923788/figure/mdz281-F1/
number: F1
caption: Signaling by the phosphatidylinositol-3-kinase (PI3K)-AKT- mammalian target
  of rapamycin (mTOR) pathway. The PI3K-AKT-mTOR pathway is activated by various growth
  factor receptors such as HER2, fibroblast growth factor receptor 1 (FGFR1), insulin-like
  growth factor 1 R (IGF1R) among others. PI3K proteins are recruited to the plasma
  membrane, leading to phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2)
  to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 recruits to the
  membrane the AKT kinases that, once activated by PDK1 and mTORC2 phosphorylation,
  are able to phosphorylate TSC2 and negatively regulate the activity of the kinase
  mTOR. mTORC1 also phosphorylates and activates S6K. Also shown are few examples
  of PI3K-AKT-mTOR inhibitors in clinical trials.
papertitle: Overview of the relevance of PI3K pathway in HR-positive breast cancer.
reftext: N Vasan, et al. Ann Oncol. 2019 Dec;30(Suppl 10):x3-x11.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.963081
figid_alias: PMC6923788__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6923788__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6923788__mdz281f1.html
  '@type': Dataset
  description: Signaling by the phosphatidylinositol-3-kinase (PI3K)-AKT- mammalian
    target of rapamycin (mTOR) pathway. The PI3K-AKT-mTOR pathway is activated by
    various growth factor receptors such as HER2, fibroblast growth factor receptor
    1 (FGFR1), insulin-like growth factor 1 R (IGF1R) among others. PI3K proteins
    are recruited to the plasma membrane, leading to phosphorylation of phosphatidylinositol
    4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3).
    PIP3 recruits to the membrane the AKT kinases that, once activated by PDK1 and
    mTORC2 phosphorylation, are able to phosphorylate TSC2 and negatively regulate
    the activity of the kinase mTOR. mTORC1 also phosphorylates and activates S6K.
    Also shown are few examples of PI3K-AKT-mTOR inhibitors in clinical trials.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - btl
  - Myb
  - Pi3K21B
  - Taf5
  - Pdk1
  - Akt
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - gig
  - pk
  - ha
  - S6k
  - Pi3K59F
  - Pi3K68D
  - Mtor
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - FGFR1
  - IGF1R
  - ERBB2
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - CUX1
  - SART3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - TSC2
  - RPS6KB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - Everolimus
  - Temsirolimus
  - AZD8055
  - GDC-0077
  - AZD6363
  - SF1126
  - LY3023414
---
